CA
TDAC

Crossingbridge Advisors’s Translational Development Acquisition Corp TDAC Stock Holding History

Crossingbridge Advisors’s Portfolio TDAC Stock Details TDAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-290,100
Closed -$3.06M – 167
2026
Q1 		$3.06M Buy
290,100
+40,100
+16% +$423K 0.55% 53
2025
Q4 		$250K Hold
250,000
– – 0.07% 91
2025
Q3 		$250K Sell
250,000
-150,000
-38% -$1.55M 0.13% 58
2025
Q2 		$4.11M Sell
400,000
-185,000
-32% -$1.88M 3.61% 7
2025
Q1 		$5.9M Buy
+585,000
New +$5.88M 3.1% 7

Other funds holding TDAC

LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.75B AUM 102.57% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.56% 1-Year Est. Return

Crossingbridge Advisors's TDAC Position: Q2 2026 in Review

Crossingbridge Advisors sold out of Translational Development Acquisition Corp (TDAC) in Q2 2026, closing a stake of 290,100 shares — an estimated $3.06M sold.

Crossingbridge Advisors first reported a position in TDAC in Q1 2025 and held it in 5 quarters. The position peaked at $5.9M in Q1 2025. 35 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

  • Crossingbridge Advisors reported no remaining Translational Development Acquisition Corp position as of Q2 2026 after selling out during the quarter.
  • Crossingbridge Advisors sold 290,100 Translational Development Acquisition Corp shares in Q2 2026, an estimated $3.06M.
  • Crossingbridge Advisors first reported a position in Translational Development Acquisition Corp in Q1 2025 and held it in 5 quarters.
  • Crossingbridge Advisors's Translational Development Acquisition Corp position peaked at $5.9M in Q1 2025.
  • 35 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on Crossingbridge Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.